Tenax Therapeutics, Inc.
(NASDAQ : TENX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.74%75.260.8%$473.31m
MDTMedtronic PLC
1.16%92.290.6%$467.57m
ISRGIntuitive Surgical, Inc.
2.32%548.502.4%$425.24m
TMOThermo Fisher Scientific Inc.
2.56%252.441.0%$395.89m
ALGNAlign Technology, Inc.
1.68%254.966.3%$378.26m
SYKStryker Corporation
0.67%186.791.3%$314.48m
BSXBoston Scientific Corporation
0.23%40.011.1%$294.43m
BDXBecton, Dickinson and Company
1.59%248.391.1%$270.36m
TFXTeleflex Incorporated
1.51%285.785.4%$247.14m
BAXBaxter International Inc.
1.38%73.441.7%$223.09m
EWEdwards Lifesciences Corporation
0.95%177.791.2%$215.36m
ABMDABIOMED, Inc.
1.19%362.063.3%$187.02m
WATWaters Corporation
1.39%234.713.5%$175.89m
ZBHZimmer Biomet Holdings, Inc.
0.94%123.641.7%$173.58m
DXCMDexCom, Inc.
0.45%148.498.5%$159.41m

Company Profile

Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and commercializing novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.